Thoratec-HeartWare LVAD Deal Is Dead Following FTC Challenge
Thoratec abandoned its planned $282 million acquisition of ventricular-assist-device-maker HeartWare July 31 after the deal was challenged by the Federal Trade Commission
Thoratec abandoned its planned $282 million acquisition of ventricular-assist-device-maker HeartWare July 31 after the deal was challenged by the Federal Trade Commission